Cutting Edge Webcasts – Infectious Diseases
Cutting Edge Technologies Webcast Series
Program Available from July 1, 2014 through March 31, 2018
 

Intended Audience
This program is intended for clinical pathologists, laboratory physicians, laboratory administrators, directors and managers; in vitro diagnostic industry professionals and other healthcare professionals involved in the diagnosis and/or management of infectious diseases.

 

Multiplex Nucleic Acid Tests for Respiratory Viruses: Technology, Applications, and Clinical Relevance (originally presented on October 16, 2013)

nolteFrederick (Rick) Nolte, PhD, Professor and Vice Chair for Laboratory Medicine, and Medical Director of Clinical Laboratories and Molecular Pathology Laboratory at the Medical University of South Carolina in Charleston, South Carolina.

Dr. Nolte describes currently available multiplex nucleic acid testing platforms and how they are being used to diagnose respiratory viruses.

 

Jessica Colon-FrancoUnderstanding the Role of Biomarkers in the Sepsis Diagnosis Algorithm (originally presented on November 12, 2013)

Jessica Colon-Franco, PhD, Assistant Professor of Pathology, Medical College of Wisconsin in Milwaukee, Wisconsin and Assistant Director of Clinical Chemistry and Toxicology, Dynacare Laboratories in Milwaukee.

 

 

Alison WoodworthAlison Woodworth, PhD, Director of Esoteric Chemistry, Associate Director of Clinical Chemistry, and Assistant Professor of Pathology, Microbiology and Immunology at the Vanderbilt University Medical Center in Nashville, Tennessee

Drs. Colon-Franco and Woodworth discuss how labs can help clinicians recognize sepsis in its early stages in order to prevent this inflammatory response from lead to complications that result in organ failure and/or death.   

 

Alexandra ValsamakisDiagnostic Testing for Hepatitis C Virus in the Era of Direct-Acting Antiviral Therapy (originally presented on December 10, 2013)

Alexandra Valsamakis, MD, PhD, Associate Professor of Pathology, Director of Clinical Virology, and Director of Molecular Microbiology at The Johns Hopkins University School of Medicine in Baltimore, Maryland

Dr. Valsamakis discusses the how labs can incorporate new recommendations for HCV screening overcome the challenges of perform diagnostic and viral load testing. 

  

Learning Outcomes - what you will be able to do after viewing these presentations:

Multiplex Nucleic Acid Tests for Respiratory Viruses: Technology, Applications, and Clinical Relevance

  • Describe the characteristics and limitations of rapid antigen testing
  • Explain the pros and cons of multiplex nucleic acid testing for detecting respiratory infections
  • Evaluate how multiplex nucleic acid testing affects clinical decision-making in caring for patients with respiratory virus symptoms

Understanding the Role of Biomarkers in the Sepsis Diagnosis Algorithm

  • Describe the laboratory's challenges in identifying sepsis
  • Explain the characteristics of effectives sepsis biomarkers
  • Evaluate the potential of procalcitonin's in a multi-marker strategy for the early identification of sepsis

Diagnostic Testing for Hepatitis C Virus in the Era of Direct-Acting Antiviral Therapy

  • Describe the recommended HCV screening guidelines and examples of how labs can put these into practice for HCV testing
  • Explain the impact of new direct-acting antiretroviral therapies on the lab's role in monitoring HCV therapy
  • Provide an update on molecular and genetic testing for HCV

To register for this program, click here.

Page Access:


faqs
Register